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Angiogenesis marks an important turning point in the growth of solid 
tumours. Avascular tumours rely on diffusive transport to supply 
them with the nutrients they need to grow and, as a result, they 
typically grow to a maximal size of several millimetres in diameter. 
Growth stops when the rate at which nutrient-starved cells in the 
tumour centre die balances the rate at which nutrient-rich cells on the 
tumour periphery proliferate. Under low oxygen, tumour cells secrete 
angiogenic growth factors that stimulate the surrounding vasculature 
to produce new capillary sprouts that migrate towards the tumour and 
the new vessels increase the supply of nutrients to the tissue, enabling 
the tumour to continue growing and to invade adjacent healthy tissue. 
At a later stage small clusters of tumour cells may enter the 
vasculature and be transported to remote locations in the body, where 
they may establish secondary tumours and metastases. 
In more detail, the process of angiogenesis involves degradation 
of the extracellular matrix, endothelial cell migration and 
proliferation, capillary sprout anastomosis, vessel maturation, and 
adaptation of the vascular network in response to the blood flow. 
Angiogenesis is initiated when hypoxic cells secrete tumour 
angiogenic factors (TAFs), such as vascular endothelial growth factor 
(VEGF). The TAFs are transported through the tissue by diffusion 
where they stimulate the existing vasculature to form new sprouts. 
The sprouts migrate through the tissue, responding to spatial 
gradients in the TAFs by chemotaxis. When sprouts connect to other 
sprouts or to the existing vascular network via anastomosis, new 
vessels arise. The diameter of perfused vessels changes in response to 
a number of biomechanical stimuli such as wall shear stress and 
signalling cues such as VEGF. Angiogenesis persists until the tissue 
segment is adequately vascularised. On the other hand, vessels which 
do not sustain sufficient blood flow will regress and be pruned from 
the network. 
The presented computational model describes the 
spatio-temporal dynamics of tumour growth in a vascular host tissue. 
Cells are represented as individual entities (agent-based approach) 
each with their own cell cycle and subcellular-signalling machinery. 
Nutrients are supplied by a dynamic vascular network, which is 
subject to remodelling and angiogenesis. The interactions between the 
different modules are depicted in Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Multiscale model overview (interaction diagram). This 
figure shows the connections between the different modelling layers. 
In the subcellular layer the cell cycle protein concentrations and the 
p53 and VEGF concentrations are modelled via systems of coupled 
ordinary differential equations. The local external oxygen 
concentration influences the duration of the cell cycles. Cells 
consume oxygen, and produce VEGF in the case of hypoxia. 
Extracellular VEGF also influences the emergence of endothelial 
sprouts and their biased random walk towards hypoxic regions. If 
endothelial sprouts connect to other sprouts or the existing vascular 
network, new vessels form. Vessel diameter is influenced by the local 
oxygen concentration and flow-related parameters, such as pressure 
and wall shear stress. The vascular network delivers oxygen 
throughout the tissue. 
 
Our model is formulated on a regular grid that subdivides the 
simulation domain into lattice sites. Each lattice site can be occupied 
by several biological cells whose movement on the lattice is governed 
by reinforced random walks, and whose proliferation is controlled by 
a subcellular cell cycle model. The vascular network consists of 
vessel segments connecting adjacent nodes on the lattice, with 
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defined inflow and outflow nodes with prescribed pressures. We also 
specify the amount of haematocrit entering the system through the 
inlets. The vessel network evolves via (i) sprouting of tip cells with a 
probability that increases with the local VEGF concentration, (ii) tip 
cell movement is described by a reinforced random walk, and (iii) 
new connections forming via anastomosis. In addition, vessel 
segments with low wall shear stress may be pruned away. Elliptic 
reaction-diffusion equations for the distributions of oxygen and 
VEGF are implemented on the same spatial lattice using finite 
difference approximations, and include source and sink terms based 
on the location of vessels (which act as sources of oxygen and sinks 
of VEGF) and the different cell types (e.g. cells act as sinks for 
oxygen and hypoxic cells as sources of VEGF). 
In summary, after initialising the system, the diffusible fields, 
cellular and subcellular states are updated (including cell division and 
movement), before the vessel network is updated, this process being 
repeated until the simulation ends. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Tumour growth in healthy tissue. The tumour cells and 
vasculature are depicted in the left column, the vasculature and 
normal cells in the middle column and the vessel network in the right 
column. The figure shows a realisation of a 50 x 50 x 50 domain with 
a cube of tumour cells implanted in healthy tissue with two straight 
initial vessels. 
 
The results from a typical simulation showing the development 
of a tumour and its associated network of blood vessels are depicted 
in Figure 2. Simulations were performed on a 50 x 50 x 50 lattice 
with spacing 40µm, which corresponds to a 2mm x 2mm x 2mm cube 
of tissue. For the following simulations, each lattice site can be 
occupied by at most one cell (either normal or cancerous), which 
implies that, for the grid size used (40µm), the tissue is loosely 
packed. A small tumour was implanted at t=0 in a population of 
normal cells perfused by two parallel parent vessels with 
countercurrent flow (i.e. the pressure drops and hence flows are in 
opposite directions). Initially, insufficient nutrient supply in 
unvascularised areas causes widespread death of the normal cells. 
The surviving tumour cells reduce the p53 threshold for death of 
normal cells, which further increases the death rate of the normal 
cells and enables the tumour to spread. Initially, most of the tumour 
cells are quiescent and secrete VEGF which stimulates an angiogenic 
response. After a certain period of time the quiescent cells die and 
only a small vascularised tumour remains encircling the upper vessel. 
The tumour expands preferentially along this vessel, in the direction 
of highest nutrient supply. Diffusion of VEGF throughout the domain 
stimulates the formation of new capillary sprouts from the lower 
parent vessel. When the sprouts anastomose with other sprouts or 
existing vessels, the oxygen supply increases, enabling the normal 
cell population to recover. Because the tumour cells consume more 
oxygen than normal cells, and they more readily secrete VEGF under 
hypoxia, VEGF levels are higher inside the tumour and the vascular 
density there is much higher than in the healthy tissue. The tumour 
remains localised around the upper vessel until new vessels connect 
the upper and lower vascular networks. Thereafter the tumour cells 
can spread to the lower region of the domain until eventually the 
domain is wholly occupied by cancer cells and their associated 
vasculature. 
As a further step we document first results of a vascular tumour 
growth simulation for which the initial vascular geometry was taken 
from multiphoton fluorescence microscopy. The aim here is to 
integrate the mathematical model with in vivo experimental data. To 
generate experimental data on in vivo tumour vasculature, we 
implanted into a mouse dorsal window chamber a tumour construct 
comprising a central core of human breast cancer cells surrounded by 
rat microvessel fragments, embedded in a collagen matrix. The cancer 
cells and rat microvascular cells express different fluorescent proteins 
so that, following implantation, the tumour and its vascular network 
can be visualised. 
 
 
 
 
 
 
 
  
            
Figure 3: Image reconstruction. We reconstructed the vascular 
network by applying the following strategy. 3D multiphoton 
fluorescence microscopy images (A) taken from mouse models in vivo 
formed the basis of our geometrical reconstruction. These images 
were transferred to OpenInventor and Matlab for image analysis. 
Based on the data we reconstructed the vascular graph model that 
describes the connectivity of the vascular network. B) We assigned 
inflow (red points) and outflow nodes (blue points) at various 
pressures in order to obtain a persistent and stable network. The 
vascular graph is characterised by the spatial coordinates of the 
nodes and the connections between them. 
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We used the experimental data to reconstruct the vascular graph 
model, locating nodes in the vessel centres and connecting them by 
edges. We use this example principally as proof-of-concept. First, we 
embed the vascular system into healthy tissue and then simulate 
vessel adaptation until a steady-state is reached. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Proof-of-concept: tumour growth in an experimentally 
derived vascular network. A)–D) show the temporal evolution of a 
tumour in a real vascular network embedded in normal tissue. As 
initial condition we have taken a vascular network from multiphoton 
fluorescence microscopy and embedded it in a 50 x 50 x50 cellular 
automaton domain. In the first column the tumour expands radially, 
and degrades the healthy tissue (second column). The predicted 
adaptations of the vascular system are shown in the third column 
where the experimentally derived network is shown in light red, while 
the new vessels are coloured in red. 
 
Currently in the models the vasculature is embedded in a 
healthy tissue into which a small tumour is implanted and its 
evolution is studied. A projection of a 3D image set of the tissue is 
presented in Figure 3. In Figure 4 we observe that the tumour expands 
radially into the surrounding healthy tissue which is degraded by the 
cancer cells by decreasing the p53 death-threshold for normal cells. 
Normal cells in the lower left and right corners of the simulation 
domain (first column) are exposed to low oxygen (hypoxia), and 
hence produce VEGF which induces an angiogenic response in our 
model. While the new vessel in the lower left corner is persistent and 
increases in radius, the vessel in the lower right corner is pruned back. 
In this case pruning occurs because the new blood vessel connects 
vessels from the initial network that have similar pressures. In general 
it can be said that the normal cells are adequately nourished by 
oxygen as only a few hypoxic cells can be observed in simulations 
with normal cells only. In contrast, we find a high percentage of 
quiescent cancer cells in all states of tumour growth, leading to 
further angiogenesis in our simulations (see Figure 4). The dark red 
vessels in row 3 indicate new vessels that develop after tumour 
implantation. In conclusion, our model predicts an increase in the 
vascular density following tumour implantation. 
